glp 1 updates GLP-1 Pipeline Update: August 2025 - Prime Therapeutics GLP-1s are no longer the

Description

Exenatide extended-release (Bydureon/BCise) carries a boxed warning regarding thyroid C-cell tumors based on rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Research in rats has shown that semaglutide is present in breast milk after maternal dosing

The Year of Orals: Convenience Meets Innovation 2026 is set to be the year of the orals, marking a major inflection point in obesity medication accessibility and patient preference

Blog Yerba Mate and GLP-1: The Effects on Blood Sugar and Weight Loss Share Table of Contents Beginning What Are Potential Side Effects of Yerba Mate

Drug Imports Alerts Database FDA Import Alerts notify field staff and the public when the agency has enough evidence to detain products without physical examination (DWPE) due to suspected violations of FDA laws, including violations of current good manufacturing practices for finished pharmaceuticals or unapproved new drugs